After DRUG resumes and goes a little lower following a halt down, there will most likely be a good bounce opportunity as dip buyers enter the market, potentially seeing a $1 to $1.50 per share bounce (e.g., from $10 to $11 or $9 to $10.50).
"I I think what'll happen is it'll resume it'll go a little lower and then you're probably going to get some dip buyers who are going to come in just because typically when you get a halt down like this and then and then it opens lower you just typically do get a little bit of a bounce so that's a setup that a lot of people are going to look for grab you know a couple thousand shares or whatever more for some people and just catch that bounce back up it could be a bounce from 10 to 11 a dollar a share could be from 9 to 1050 $150 a share but there'll be most likely a good bounce opportunity on this"